Skip to main content

Your search for “Medicine” returned 3375 results

UC San Diego Part of New Effort to Fight Autoimmune Disorders

September 25, 2014

…Immunology at University of California, San Diego School of Medicine has been named a key site in a national, multi-institution, multi-year $41.6 million program to speed drug discovery, development, diagnostics and therapies for patients with autoimmune disorders, primarily rheumatoid arthritis (RA) and lupus erythematosus, which affect millions of Americans.

How Gene Therapy May Hold Key to Treating Life-Threatening Cardiac Disease

March 18, 2020

New study finds gene therapy improved cardiac, muscle and liver function in Danon disease mouse models.

A New Approach to Faster Anticancer Drug Discovery

March 13, 2012

Tracking the genetic pathway of a disease offers a powerful, new approach to drug discovery, according to scientists at the University of California, San Diego School of Medicine who used the approach to uncover a potential treatment for prostate cancer, using a drug currently marketed for congestive heart failure.

Personality Traits and Psychiatric Disorders Linked to Specific Genomic Locations

December 8, 2016

…researchers at University of California San Diego School of Medicine in this week’s advance online publication of Nature Genetics. The findings also show correlations with psychiatric disorders.

New Cancer Council Combines Local Centers’ Strengths

March 6, 2013

San Diego is a powerhouse for cancer research, home to the University of California, San Diego Moores Cancer Center – the region’s only National Cancer Institute (NCI)-designated comprehensive cancer center – and two NCI-designated centers for basic research: the Salk Institute Cancer Center and the Cancer Center at Sanford-Burnham Medical…

UC San Diego Nets Another Top Global Ranking

March 19, 2015

…university to determine what medicines and pharmaceutical drugs could be developed from raw materials found in the sea. In a bold step to more quickly translate the regenerative power of stem cells into real-world therapies, U.S. businessman and philanthropist T. Denny Sanford committed $100 million to the creation of the…

COVID-19 Rebound after Taking Paxlovid Likely Due to Insufficient Drug Exposure

June 21, 2022

COVID-19 rebound following Paxlovid treatment likely due to insufficient drug exposure, UC San Diego researchers find after showing rebound patient did not show drug resistance or impaired immunity.

New Insights into 3D Genome Organization and Genetic Variability

February 18, 2015

While genomics is the study of all of the genes in a cell or organism, epigenomics is the study of all the genomic add-ons and changes that influence gene expression but aren’t encoded in the DNA sequence. A variety of new epigenomic information is now available in a collection of…

Treated or Not, COVID-19 Recurrence Seems Symptomatic for Some

October 31, 2022

UC San Diego researchers and others report that more than one-third of the COVID-19 patients who did not receive any treatment experienced complete resolution of symptoms for at least two consecutive days, but then subsequently reported a return of symptoms.

Two UC San Diego Scientists Elected to National Academy of Medicine

October 18, 2021

Leaders in cell biology and anti-malarial drug development respectively, JoAnn Trejo and Elizabeth Winzeler were recognized by their peers with one of the highest honors in health and medicine.

Category navigation with Social links